To further investigate this phenomenon, we used unsupervised clustering and identified two Treg subpopulations, defined as Treg A and Treg B. Treg B gradually increased with MASLD progression and showed high expression of CD29, which was also identified as a high‐risk scoring gene. The gene discussed is ITGB1; the disease is metabolic dysfunction-associated steatotic liver disease.